Status:

COMPLETED

Color Synbiotics Study

Lead Sponsor:

Danone Asia Pacific Holdings Pte, Ltd.

Conditions:

Beneficial Bacteria in Gut

Eligibility:

All Genders

43-65 years

Phase:

NA

Brief Summary

This study is initiated to investigate the effect of infant formula with added specific synbiotics mixture on proportion of beneficial bacteria.

Eligibility Criteria

Inclusion

  • Healthy term infants (gestational age ≥ 37 1/7 and ≤ 41 6/7 weeks) aged 46 - 65 days (inclusive) at entry into the study
  • Fully formula fed for at least one week (not applicable for the breastfeeding reference group since these infants must be exclusively breastfed before and throughout the study)
  • Parents' or legal guardian's written informed consent

Exclusion

  • Exclusion criteria for run-in period (visit 1, screening) are:
  • Being weaned before inclusion (introduction of any other foods other than formula or human milk)
  • Moderate or severe acute malnutrition, defined as weight-for-age and sex below -2 z-scores of the median WHO growth standards
  • Medical condition for which a special diet other than standard (non hydrolised) cow's milk-based infant formula is required
  • Known congenital diseases or malformations which could interfere with the study (e.g. gastrointestinal malformations, congenital immunodeficiency), as per investigator's clinical judgement
  • Use of systemic antibiotics or anti-mycotic drugs in the 4 weeks prior to entry into the study
  • Received Inactivated Poliovirus Vaccine (IPV) or Rotavirus Vaccine (RV) prior to entry into the study
  • Gastroenteritis or diarrhoea in the last two weeks prior to entry into the study
  • Participation in any other studies involving investigational or marketed products concomitantly or within two weeks prior to entry into the study
  • Investigator's uncertainty about the willingness or ability of the parents to comply with the protocol requirements

Key Trial Info

Start Date :

May 1 2013

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 1 2016

Estimated Enrollment :

290 Patients enrolled

Trial Details

Trial ID

NCT01813175

Start Date

May 1 2013

End Date

July 1 2016

Last Update

September 7 2017

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Thammasat Hospital

Klong Luang, Changwat Pathum Thani, Thailand

2

King Chulalongkorn Memorial Hospital

Bangkok, Thailand

3

Phramongkutklao Hospital

Bangkok, Thailand